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Abstract
Objective: This study aimed to evaluate the knowledge, attitude and prescription practice of menopausal-
HRT (mHRT) by doctors in UITH, Ilorin. 
Method: All consenting doctors in O&G, Internal Medicine, Family Medicine, Public Health and Interns 
at the UITH completed a structured questionnaire. SPSS software version 22 was used for analysis. 
Associations between categorical variables were tested using the chi-square (÷2) while the student-t test 
was used for the continuous variables (p <0.05).
Results: Eighty doctors, 56 males and 24 females responded. Majority (63.8%) rated their knowledge of 
mHRT average; (17.5%) believed they had good knowledge, while (18.7%) had poor knowledge. 
Gynaecologists had the highest mHRT Knowledge Score (72.4) while public health doctors had the lowest 
(33.7), (83.7%) had no formal training on the use of mHRT. Fifty-five percent did not think menopause 
should be treated. Just 25% prescribed mHRT where 58.8% had no reason for not prescribing. Only 18.8% 
had ever referred menopause patients to specialists. Forty percent use alternative therapies for 
menopausal symptoms, majorly vitamins and herbs.
Conclusion: The knowledge, attitude and prescription practice of the studied doctors was poor. Trainings 
are still needed in this area. 
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Connaissance, attitude et prescription pratique de la thérapie de 
remplacement de l'hormone menopausal par des médecins d'UITH, 
Ilorin, Nigéria
* 1 2 3 4 5 1




Cette étude visait à évaluer les connaissances, l'attitude et la pratique en matière de prescription de HRT 
ménopausique (mHRT) par des médecins d'UITH, Ilorin.
Méthode de l'étude: Tous les docteurs en O & G, en médecine interne, en médecine familiale, en santé 
publique et en santé publique et les stagiaires de l'UITH ont rempli un questionnaire structuré. La version 
22 du logiciel SPSS a été utilisée pour l'analyse. Les associations entre les variables catégorielles ont été 
testées à l'aide du chi-carré (2), tandis que le teste d'étudiant était employé pour les variables continues (p 
<0.05).
Résultat : Quatre –vingt (80) médecins, 56 hommes et 24 femmes ont répondu. La majorité (63.8%) ont 
évalué leur connaissance de la moyenne de mHRT; (17.5%) pensaient avoir de bonnes connaissances, 
alors que (18.7%) avaient de faibles connaissances. Les gynécologues avaient le score de connaissances 
mHRT le plus élevé (72.4), tandis que les médecins de la santé publique avaient le score le plus bas (33.7),  
(83.7%) n'avait aucune formation officielle sur l'utilisation des mHRT. Cinquante-cinq pour cent ne 
pensaient pas que la ménopause devrait être traitée. Seulement 25% ont prescrit un mHRT alors que 58.8% 
n'avaient aucune raison de ne pas le prescrire. Seulement 18.8% avaient déjà référé des patientes 
ménopausées à des spécialistes. Quarante pour cent ont recours à des thérapies alternatives pour traiter les 
symptômes de la ménopause, principalement les vitamines et les herbes.
 
Conclusion: Les connaissances, l'attitude et la pratique en matière de prescription des médecins étudiés 
étaient médiocres. Des formations sont encore nécessaires dans ce domaine.
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INTRODUCTION
Menopause is a physiological event that 
signifies the end of a woman's 33 reproductive 
life due to permanent loss of ovarian follicular 
function (1). The hormonal changes at 
menopause are associated with numerous 
physical, emotional and sexual dysfunctions of 
varying severity. Among the commonly 
encountered symptoms of menopause are hot 
flushes, vaginal dryness with dyspareunia, 
urogenital symptoms, mood changes, sleep 
disorders as well as osteoporosis and heightened 
risk of cardiovascular disease (1,2).
Over the years, Hormone Replacement 
Therapy (HRT) has been used successfully to 
treat menopause-related vasomotor symptoms 
and to protect against osteoporosis (2). However, 
a number of side-effects have also been observed 
with its use. Women's Health Initiative (WHI), a 
multi-centre randomised controlled trial of 
Oestrogen plus Progestin among 16,608 
American post-menopausal women with intact 
uteruses showed a significant increase in hazard 
risk for invasive breast cancer, stroke, coronary 
artery disease and venous thrombosis (3). On the 
other hand, according to the study, menopausal – 
HRT (mHRT) seemed to be protective against 
osteoporosis, colorectal cancer and endometrial 
carcinoma (3). 
Some researchers however tried to do a 
re-analysis of the WHI data and found that the 
side effects may not be as serious as earlier 
portrayed (4,5). In spite of this, many physicians 
and patients still have reasons to question the 
safety of menopausal hormone therapy (6). There 
is also no consensus among the various practice 
regulatory bodies with regards to use of HRT in 
menopause. 
In an Enugu based study in 2009, less 
than 1% of the 209 women studied were aware of 
mHRT and none had ever been treated with it (7). 
A similar study carried out in Benin showed that 
none of the women studied was on mHRT and 
only 7.3% had awareness about it (8). This is 
partly because of unwillingness on the part of the 
women to use them and also because of 
prescription inertia on the part of the physicians. 
A recommendation by a doctor is a major 
determinant of mHRT use among the women. 
Majority of non-users would consider mHRT if 
so recommended by their doctor (2,9).
It is important therefore that doctors 
attending to menopausal women familiarise 
themselves with the current guidelines in the use 
of mHRT and form a practice opinion that is 
evidence-based and that will give optimal quality 
of mid-life health to their clients. This study 
therefore set out to evaluate the doctors' 
knowledge, attitude and prescription practice of 
HRT for menopause-related symptoms.
General Objective
To determine the knowledge, attitude and current 
prescription practice of menopause-HRT 
(mHRT) by doctors in University of Ilorin 
Teaching Hospital (UITH), Ilorin, Nigeria.
Specific objectives
1. To determine the knowledge base of the 
doctors concerning the indications, 
contra-indications, effects and side 
effects of mHRT use in menopause
2. To assess their views and attitudes about 
use of mHRT to treat menopausal 
symptoms
3. To determine their current prescription 
practice.
MATERIALS AND METHODS
Study Site: The study took place at University of 
Ilorin Teaching Hospital (UITH), Ilorin, Nigeria. 
Ilorin is the capital city of Kwara state located in 
the Middle Belt of the country with a population 
of 781, 934 according to 2006 national 
population census (10). The hospital is a 500-bed 
third-tier healthcare facility that serves as a 
referral centre for the whole state and its 
environs. It has virtually all the major clinical 
departments and units like Internal medicine, 
Surgery, Obstetrics and Gynaecology, 
Paediatrics, Family Medicine, Geriatrics as well 
as Community Medicine and Public Health.
Study Design: It was a descriptive cross-
sectional study.
Study Population: All medical practitioners in 
UITH attending to women in menopausal age 
group
Sample Size Determination: All consenting 
doctors that met the inclusion criteria
Inclusion Criteria
1. Al l  doctors  in  Obste t r ics  and 
Gynaecology Department
2. Doctors in Internal Medicine
3. Family Physicians
4. Public Health Physicians 
5. Interns
Exclusion Criteria
1. Any doctor that was not in active practice 
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Ethical Consideration: Ethical approval for the 
study was gotten from the Ethics and Research 
Committee of the University of Ilorin.
Benefit to Science: Doctors are known to play 
crucial role in providing medical education for 
patients in Africa. The results from this study will 
help in formulating a policy about training and re-
training of healthcare specialists in Nigeria with 
regards to management of menopause-related 
complaints.
Benefit to Individuals: Up-to-date knowledge 
and evidence-based practice among the doctors 
will assist them to take health decisions that will 
improve the overall quality of life for climacteric 
Nigerian women.
Funding: The study was fully funded by the 




Eighty doctors were recruited from the 
University of Ilorin Teaching Hospital in Kwara 
State. 70% (56) male and 30% (24) female. 
Majority 67(83.75%) were of the Yoruba tribe 
while the remaining 13(16.25%) were from other 
ethnic groups. Twenty-four (30%) were from the 
department of internal medicine, 13 (16.2%) 
were from Family Medicine, 19 (23.8%) were 
from Obstetrics and Gynaecology, 15(18.8%) 
were Public Health physicians while the 
remaining 9 (11.2%) were Interns. A total of 46 
(57.5%) were Christians while 33 (41.3%) were 
Muslims while one of the respondents did not 
subscribe to any religion.
Doctor's Knowledge of mHRT
From the self-assessment of mHRT 
knowledge, a huge majority 51 (63.8%), rated 
their knowledge average; only 14 (17.5%) 
believed they had good knowledge of HRT, while 
15 (18.7%) admitted that their knowledge of 
menopausal-HRT was poor. Only 13 (16.3%) 
claimed to have had any formal training on the 
use of menopausal hormone replacement therapy 
in the last 5years, the other 67(83.7%) agreed 
they had no formal training. 
As many as 20 (25%) of the doctors did 
not have any source of information about mHRT; 
32 (40%) referred to textbooks, 17 (21.3%) 
consulted journals, 7(8.8%) said they got 
information from lectures, 3(3.8%) claimed to 
have accessed mHRT information through the 
during the study period
2. Any doctor not regularly attending to 
women in menopause or peri-menopause 
(less than 5 per month)
Method
Each study candidate was interviewed via a self-
administered questionnaire with several domains 
including:
1. Socio-demographics
2. Knowledge of mHRT
3. Views and attitudes towards mHRT
4. Prescription practice of mHRT
Research Instrument
The research tool was a self-administered 
questionnaire developed from some other 
questionnaires that have been used in previously 
published works on the same topic (11,12,13). 
The questionnaire is a 57-item questionnaire 
under 3 domains:
i. Knowledge domain has 29 questions on 
indications and contra-indications to the 
use of mHRT
ii. Attitude domain has 16 questions while
iii. Practice domain has 12 questions
Scoring of Domains: Domain scores are based 
on the current practice guidelines on menopausal 
1HRT . A mark was awarded for a correct answer 
while a wrong answer or un-attempted question 
attracted no mark.
Knowledge Score: The global Knowledge Score 
was computed by transforming the sum total 
score for Knowledge Domain on a scale of 0 to 
100, where 0 represents “No knowledge at all” 
and 100 represents “highest knowledge 
attainable”.
Sampling Technique: The doctors that met the 
inclusion criteria were identified and contacted. 
Detailed information about the study was given to 
all the prospective candidates and questionnaires 
were served following verbal consent.
Statistical Analysis: Data were analysed using 
the SPSS statistical software version 22 (14). 
Continuous variables were generated as means ± 
s.d while the categorical variables were presented 
as frequency and proportions. Associations 
between categorical variables were tested using 
2the chi-square (÷ ) while the student-t test was 
used for the continuous variables. A p value of 
<0.05 was taken as statistically significant 
difference.
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Endometrial Carcinoma and Deep Vein 
Thrombosis while up to (65%) of them felt same 
way for women with stroke. mHRT was deemed 
contraindicated in hypertension by 36 (45%) and 
26 (32.5%) for women with diabetes mellitus.  
Doctor's Practice of mHRT
Out of the 80 doctors that responded, a 
total 76 (95%) indicated that they attended to 
menopause women while the remaining 4(5%) 
did not. Twenty (25%) saw more than 10 
menopausal women every month, 24 (30%) saw 
between 5 and 10, while 32 (40%) did not see 
beyond 5 menopause women in a month. 
Although as many as 59 (73.8%) out of 
the 80 respondents indicated that they 
encountered menopause-related symptoms on a 
regular basis, only 29 (36.3%) of the 80 doctors 
discussed menopause with their patients.
It is worthy of note that, only a quarter, 20 
(25%) of the 80 respondents prescribed HRT in 
any form for menopause related symptoms, 
60(75%) did not prescribe at all.  
Twelve (15%) did not prescribe mHRT for fear of 
side effects, 47 (58.8%) had no reason for not 
prescribing while the remaining one person did 
not believe in mHRT at all.
Twelve (15%) prescribed oral form of 
mHRT, 6(7.5%) prescribed vaginal cream while 
2(2.5%) prescribed injectable. Whereas, out of 
the 20 doctors that prescribed mHRT, only five 
(25%) indicated that they encountered side 
effects, 15(75%) admitted mHRT was quite 
effective.
With regards to patient referral, only 
15(18.8%) out of the 80 respondents had ever 
referred patients to a specialist because of 
menopause issues, 11 (73.3%) out of these 15 
doctors referred to the gynaecologists, 2(13.3%) 
of them referred to physicians while the 
remaining 2(13.3%) did not indicate the specialty 
they refer to.
32 (40%) of the 80 doctors indicated that 
they used alternative methods to treat menopause 
symptoms. 19(23.75%) prescribed vitamins, 10 
(12.5%) encouraged the use of herbal mixtures 
while the remaining 3(3.75%) did not indicate 
what they prescribed as alternative method.
DISCUSSION
This is the first time the knowledge base 
of health care providers about use of menopausal 
hormone replacement therapy is being evaluated 
in Nigeria. Majority of the studied doctors lacked 
self-confidence when handling issues about 
mHRT. This study shows that only a very small 
internet while one of the respondents had 
multiple sources of information. 
On the use of mHRT, 28 (35%) of the 
respondents submitted that they had no idea of 
how long HRT should be administered. Twenty-
one (26.25%) felt it should not be taken for more 
than 5years, an equal proportion of respondents 
also felt mHRT could be used for up to 10years, 
2(2.5%) said it could be used for more than 
10years while 8 (10%) believed it could be used 
indefinitely.
Doctor's mHRT Knowledge Score 
Mean mHRT knowledge score was 53.3 
(±2.8) as shown in Table 4. The study shows that 
male doctors have significantly higher 
knowledge scores (57.4) than their females 
counterparts (44) (p=0.03). The gynaecologists 
had the highest mHRT knowledge score (72.4) 
while the public health physicians had the lowest 
rating of 33.7 (p=0.00).
A linear association was observed in the mHRT 
knowledge score and Awareness. Those who 
claimed to have good awareness of mHRT had a 
significantly higher score (71.2) than those with 
poor awareness (45) (p=0.03), while those who 
had formal training also had a significantly higher 
score (73.1) than those without any formal 
training (p=0.007).
There was no significant association between 
knowledge of HRT and year of graduation 
(p=0.25) nor with age group (p=0.155). In 
addition, no observable difference in the doctors' 
knowledge of HRT between the two main 
religious groups in Nigeria. (p=0.641).
Doctor's Recommendation of mHRT for 
Treatment of Menopausal Symptoms 
From the study, 21 (26.3%) believed menopause 
is a physiological condition, 57 (71.2%) believed 
that menopause symptoms are clinical 
conditions, while 2 (2.5%) of the doctors agreed 
they don't know.
Out of the 80 doctors, 33(41.2%) thought 
menopausal symptoms should be treated, 44 
(55%) believed it should not be treated clinically 
while 3 (3.8%) said they don't actually know.
Doctor's Opinion on Contraindications to use 
of mHRT (Table 3) 
Sixty-five (81.3%) doctors were of the 
opinion that mHRT was contraindicated in 
women with breast cancer and 56% of them 
would not recommend it for patients with family 
history of breast cancer. About equal number 58 
(72.5%) opined that mHRT should not be used in 
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interviewed (88.8%) were aware of the positive 
benefits of mHRT in relieving vasomotor 
symptoms like hot flushes, vaginal dryness and 
dyspareunia only a very few believed in its 
usefulness in cardio-protection and stroke 
prevention. Other symptoms that seem to enjoy 
the attention of doctors in menopause include loss 
of libido and osteoporosis.  Earlier studies 
looking at the benefits of menopause - HRT 
showed that mHRT had a complex pattern of risk 
and benefits 16,23). While it was considered 
appropriate for symptom management in some 
women, its use for chronic disease prevention had 
to be done with caution (16). A more recent re-
analysis of the same old data however opined that 
the side effects attributable to MHRT might not 
be as deleterious as earlier claimed (17).
Almost all the doctors interviewed attend 
to women in post-menopausal age group and 
encounter menopausal symptoms quite 
reasonably well. But it is surprising that only 
36.3% discuss menopause with their patients and 
only 25% have ever prescribed MHRT in any 
form at any time. Most doctors do not have any 
reason for not prescribing while some hesitate to 
prescribe because of fear of side effects. In the 
earlier referenced Middle-East study (15), 88% 
of the Primary Health Care physician studied 
discussed menopausal symptoms with their 
clients while 45.1% recommended mHRT for 
them. This shows that the prescription rate for 
mHRT among Nigerian doctors is quite low 
compared to other parts of the world. This figure 
is however a slight improvement over the 
findings in some earlier Nigerian studies where 
prescription was absolutely nil (7,8).
Nigerian doctors need to update their 
knowledge of HRT to treat menopausal 
symptoms, such that those who would benefit 
from hormonal intervention will not be denied 
and the others would not be unduly exposed to the 
side effects. This will enhance the overall health-
related quality of life of the women in this age 
group. It is particularly imperative because, with 
global improvement in health standard, more 
women will spend longer period of their lives in 
menopausal years, and their doctors need to have 
enough knowledge base to provide optimal, 
evidence-based health care (1,3).
Majority (75%) of prescribers in our 
study found mHRT to be effective and a very 
small proportion of them (25%) encountered at 
least one side effect during its use. This finding is 
consistent with existing literatures and practice 
guidelines where menopause HRT is judged to be 
effective for control of menopausal symptoms 
proportion of the physicians in UITH Ilorin 
(17.5%) demonstrated self-confidence in the 
practice of mHRT, while a vast majority (63.8%) 
admitted that their knowledge about use of 
mHRT in treating menopausal symptoms was 
only average.  
In Africa, most women in the post-
menopausal age group are illiterate and therefore 
depend heavily on their doctors and other health 
care providers for health-related information 
(7,8). Where the knowledge base and self-
confidence of the health care provider (HCP) is 
lacking or deficient, it will impact negatively on 
the patients' overall health-related quality of life 
(7,8).
In spite of a plethora of information 
about menopausal hormone therapy available in 
the public domain like journals, review articles 
and practice guidelines (7,8,15,16,17,18,19). It is 
surprising to note in this study that as many as 
25% of the studied physicians claimed that they 
did not have any source of information at all 
about mHRT. Only 16.3% had at least one update 
training related to menopause care in the past 5 
years. These figures are comparable to the 
findings in a similar study (15) in the Middle East 
where 82.4% of primary health care physicians 
surveyed had just moderate knowledge of 
mMHRT (15). In that same study, the majority of 
the respondents were oblivious of the benefits of 
mHRT described in literatures. 
Using the menopause - HRT Knowledge 
Score, the mean mHRT score was 53.3. This 
clearly showed that the mHRT-knowledge base 
of doctors attending to menopausal women in 
Ilorin, Nigeria was grossly deficient compared to 
results from other developed countries 
(13,16,17). A similar study carried out in Ontario, 
Canada showed that the physicians' knowledge 
a b o u t  m H RT  w a s  c o n s i s t e n t  w i t h  
recommendations in the published literature (13).
Our study also found out that the gender 
of the doctor, the speciality of practice, access to 
formal training and re-training as well as self-
perception were the factors that were 
significantly associated with mHRT knowledge. 
Ma le  doc to r s  appea red  t o  be  more  
knowledgeable. This is paradoxical in the sense 
that women would naturally be expected to take 
more interest in women health. Those who had 
formal training in menopause as well as those in 
Obstetrics and Gynaecology appeared to fare 
better than others. Religion, tribe and graduation 
year of the doctors did not appear to play any 
significant role.
In our study, most of the physicians 
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Najjar AA, Makboul GM, Elshazly M. 
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towards management of postmenopausal 
symptoms. Alexandria Journal of Medicine. 
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16. Manson, J.E., Chlebowski, D.R.T., Stefanick, 
M.L., Aragaki, M.A.K., Rossouw, J.E., Prentice, 
R.L., Anderson, G., Howard, B.V., Thomson, 
C.A., LaCroix, A.Z. and Wactawski-Wende, J., 
2013. The Women's Health Initiative hormone 
therapy trials: update and overview of health 
outcomes during the intervention and post-
with minimal side effects if patients are well 
selected. It is now self-evident that doctors in 
Nigeria need to update their knowledge of mHRT 
to beat their prescription inertia.
With respect to the use of alternative 
treatment options for managing menopausal 
symptoms, close to half (40%) of the subjects 
used one form of alternatives or the other. The 
most commonly used alternatives were vitamins 
and herbs. A similar cross-sectional study showed 
that most Nigerian gynaecologists preferred to 
treat severe menopausal symptoms with 
psychotherapy and anxiolytics (21).   Several 
other therapeutic alternatives abound globally for 
combating climacteric symptoms but they have 
not been well studied in Africa (8,21). It would be 
desirable to subject these products to thorough 
scientific scrutiny before committing them to 
clinical use.
CONCLUSION
The knowledge base of doctors in Ilorin, 
Nigeria about menopause-HRT was far less than 
their counterparts in developed countries. 
Training and continuous re-training in use of 
mHRT should be encouraged in all medical 
schools and residency training programmes in 
Nigeria. This will foster evidence-based practice 
among the physicians and thus promote 
menopausal health-related quality of life.
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Table 1. Opinions on efficacy of menopause-HRT 
 
Menopause Symptoms N (%) Effective N (%) Ineffective N (%) Don’t Know 
Hot flushes 71 (88.8) 4 (5) 5 (6.3) 
Vulvo-Vaginal Symptom 60 (75) 7 (8.8) 13 (16.3) 
Low Sex Drive 51 (63.8) 10 (12.5) 19 (23.8) 
Skin Wrinkles 35 (43.8) 17 (21.3) 28 (35) 
Dementia 20 (25) 30 (37.5) 30 (37.5) 
Osteoporosis 67 (83.8) 6 (7.5) 7 (8.8) 
Coronary Heart Disease 19 (23.8) 40 (50) 21 (26.3) 
Stroke Prevention 17 (21.3) 40 (50) 23 (28.8) 
 
 
Table 2. Attitudes to recommendation of menopause-HRT 
 






Hot flushes 66 (82.5) 8 (10) 6 (7.5) 
Libido 60 (75) 13 (16.3) 7 (8.8) 
Vulvo-Vaginal Symptoms 57 (71.3) 13 (16.3) 10 (12.5) 
Skin Wrinkles 32 (40) 34 (42.5) 14 (17.5) 
Mood Changes 53 (66.3) 16 (20) 11 (13.8) 
Sleep Disorder 33 (41.3) 10 (12.5) 11 (13.8) 
Osteoporosis 66 (82.5) 10 (12.5) 4 (5) 
Cardiovascular Disease 30 (37.5) 41 (51.3) 9 (11.3) 
 
 








Hypertension  36 (45) 32 (40) 12 (15) 
Diabetes Mellitus 26 (32.5) 41 (51.3) 13 (16.3) 
Obesity 32 (40) 35 (43.8) 13 (16.3) 
Stroke 52 (65) 14 (17.5) 14 (17.5) 
Breast Cancer 65 (81.3) 5 (6.3) 10 (12.5) 
Fam Breast Cancer 45 (56.3) 25 (31.3) 10 (12.5) 
CLD 49 (61.3) 19 (23.8) 12 (15) 
Fibroid 23 (28.8) 42 (52.5) 15 (18.8) 
DVT 58 (72.5) 11 (13.8) 11 (13.8) 
Vaginal Bleeding  31 (38.8) 31 (38.8) 18 (22.5) 
Endometrial Carcinoma 58 (72.5) 11 (13.8) 11 (13.8) 
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Table 4. Meanopause-HRT knowledge scores compared for different variables 
 
Variable N Score S.D ANOVA Association p Value 
GENDER       
Male 56 53.4 19.9    
Female 24 46.0 17.2 2.48 0.12 0.03*** 
 
ETHNICITY       
Yoruba 67 49.2 19.9    
Igbo 3 65.0 5.0    
Hausa 1 50.0 -    
Nupe 1 70.0 -    
Others 8 60.6 14.7 1.30 0.07 0.28 
 
RELIGION       










0.68 0.02 0.51 
 
SPECIALITY       
O&G 19 61.6 13.0    
Physicians 24 52.5 19.1    
Family Med 13 44.6 19.6    
Public Health 15 35.6 17.8    
Interns 9 61.1 15.2 6.0 0.24 0.00*** 
 
HRT AWARENESS       
Good 14 58.1 24.6    
Moderate 51 53.3 16.7    
Poor 15 38.2 18.6 3.14 0.11 0.03*** 
 
SOURCE OF INFO       
Journals 17 55.6 17.3    
Textbooks 32 55.0 17.6    
Lectures 7 50.7 29.6    
Internet 3 50.0 18.0    
Multiple 1 60.0     




      
Yes 13 68.1 13.9    
No 67 47.9 18.7 6.80 0.15 0.02*** 
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